HOME > BUSINESS > Article

Text Size

small

medium

large


Shionogi to Acquire Torii Pharmaceutical

Shionogi to Acquire Torii Pharmaceutical

Isao Teshirogi (center), president and CEO of Shionogi, shakes hands with Nobumasa Kondo (right), president and CEO of Torii Pharmaceutical, and Koji Shimayoshi, executive vice president at Japan Tobacco, in Tokyo on Wednesday.
Isao Teshirogi (center), president and CEO of Shionogi, shakes hands with Nobumasa Kondo (right), president and CEO of Torii Pharmaceutical, and Koji Shimayoshi, executive vice president at Japan Tobacco, in Tokyo on Wednesday.

   Tokyo, May 7 (Jiji Press)--Japanese drugmaker Shionogi & Co. said Wednesday that it will acquire Torii Pharmaceutical Co., a unit of Japan Tobacco Inc., for about 160 billion yen.
   Shionogi will aim to make Torii a fully owned subsidiary by conducting a tender offer and buying JT's stake in the firm. JT will fully withdraw from the pharmaceutical business, transferring all related operations other than Torii to Shionogi as well.

To read a full story, please click here to find out how to subscribe.

BUSINESS

HEADLINES

POLITICS
EU Proposes Establishment of Security Cooperation Framework with Australia
ECONOMY
Average Weekly Rice Price at Japan Supermarkets Hits Record High of 4,268 Yen/kg
SPORTS
Sumo: Onosato Keeps Sole Lead in Top Division at 9-0 at Summer Grand Tournament
OTHER
Japanese Princess Aiko Interacts with Locals in Noto Region Hit by 2024 Quake

AFP-JIJI PRESS NEWS JOURNAL


Photos